Age Related Hearing Loss clinical trials

Explore recruiting age related hearing loss clinical trials.

Recruiting age related hearing loss studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Age Related Hearing Loss trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A double-blind, placebo-controlled, randomised phase 1/2a study to evaluate the safety, tolerability and pharmacokinetics of single and repeated subcutaneous ascending-doses of DX243 in healthy volunteers followed by an extension to assess 1-month safety and preliminary efficacy in patients with mild age-related hearing loss.

Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Age Related Hearing Loss trials by city

Age Related Hearing Loss in Toronto Age Related Hearing Loss in Vancouver Age Related Hearing Loss in Montreal Age Related Hearing Loss in Calgary Age Related Hearing Loss in Edmonton Age Related Hearing Loss in Ottawa Age Related Hearing Loss in Winnipeg Age Related Hearing Loss in Quebec City Age Related Hearing Loss in Hamilton Age Related Hearing Loss in Kitchener Age Related Hearing Loss in London Age Related Hearing Loss in Halifax Age Related Hearing Loss in New York Age Related Hearing Loss in Los Angeles Age Related Hearing Loss in Chicago Age Related Hearing Loss in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease